1. Tools for the Economic Evaluation of Precision Medicine: A Scoping Review of Frameworks for Valuing Heterogeneity-Informed Decisions

   • Reka E. Pataky
   • Stirling Bryan
   • Dean A. Regier

   Scoping Review 27 July 2022 Pages: 931 - 941

   

2. Current Practices for Accounting for Preference Heterogeneity in Health-Related Discrete Choice Experiments: A Systematic Review

   • Suzana Karim
   • Benjamin M. Craig
   • Catharina G. M. Groothuis-Oudshoorn

   Systematic Review 12 August 2022 Pages: 943 - 956

   

3. China Health Related Outcomes Measures (CHROME): Development of a New Generic Preference-Based Measure for the Chinese Population

   • Jing Wu
   • Xiaoning He
   • for the CHROME Study Group

   Original Research Article 18 July 2022 Pages: 957 - 969

   

4. Collaborating with Patient Partners to Model Clinical Care Pathways in Major Depressive Disorder: The Benefits of Mixing Evidence and Lived Experience

   • Mary Bunka
   • Shahzad Ghanbarian
   • Stirling Bryan

   Original Research Article Open access 25 July 2022 Pages: 971 - 977

5. Budget Impact Analysis of Vibegron for the Treatment of Overactive Bladder in the USA

   • Jing Voon Chen
   • James C. Gahn
   • Paul N. Mudd, Jr.

   Original Research Article Open access 26 July 2022 Pages: 979 - 988

   

6. A Comparison of the Content and Consistency of Methodological Quality and Transferability Checklists for Reviewing Model-Based Economic Evaluations

   • Ka Keat Lim
   • Rositsa Koleva-Kolarova
   • Julia Fox-Rushby

   Original Research Article 30 July 2022 Pages: 989 - 1003

7. Developing an Online Infrastructure to Enhance Model Accessibility and Validation: The Peer Models Network

   • Stephanie Harvard
   • Amin Adibi
   • Mohsen Sadatsafavi

   Research Letter 30 July 2022 Pages: 1005 - 1009

   

8. Comment on “Cost-Effectiveness Analysis of Herpes Zoster Vaccination in 50- to 85-Year-Old Immunocompetent Belgian Cohorts: A Comparison between No Vaccination, the Adjuvanted Subunit Vaccine, and Live-Attenuated Vaccine”

   • Nikolaos Giannelos
   • Marie Libérée Nishimwe
   • Nicolas Lecrenier

   Letter to the Editor Open access 26 September 2022 Pages: 1011 - 1012

9. Authors’ Reply to Comment on “Cost-Effectiveness Analysis of Herpes Zoster Vaccination in 50- to 85-Year-Old Immunocompetent Belgian Cohorts: A Comparison Between No Vaccination, the Adjuvanted Subunit Vaccine, and Live-Attenuated Vaccine”

   • Joke Bilcke
   • Philippe Beutels

   Letter to the Editor 26 September 2022 Pages: 1013 - 1014